We are live on ! Find out more
NM

Newtyn Management Portfolio holdings

AUM $936M
1-Year Est. Return 27.23%
This Fund
S&P 500
This Quarter Est. Return
-14.94%
1 Year Est. Return
+27.23%
3 Year Est. Return
+51.99%
5 Year Est. Return
+55.23%
10 Year Est. Return
+165.15%
AUM
$1.06B
AUM Growth
+$288M
Cap. Flow
+$463M
Cap. Flow %
43.54%
Top 10 Hldgs %
68.28%
Holding
41
New
9
Increased
15
Reduced
5
Closed
1

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 11.7%
2 Technology 4.27%
3 Healthcare 3.49%
4 Consumer Staples 3.48%
5 Industrials 3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PETS icon
26
PetMed Express
PETS
$41.7M
$9.48M 0.89%
525,999
MVST icon
27
Microvast
MVST
$269M
$9.31M 0.88%
950,000
+25,000
+3% +$247K
CAAP icon
28
Corporacion America
CAAP
$4.21B
$9.27M 0.87%
2,046,000
+1,186,327
+138% +$7.53M
TLRY icon
29
Tilray
TLRY
$618M
$7.52M 0.71%
30,404
+17,964
+144% +$6.55M
THCAU
30
DELISTED
Tuscan Holdings Corp. II Unit
THCAU
$7.44M 0.7%
+740,000
New +$7.44M
LSAK icon
31
Lesaka Technologies
LSAK
$396M
$6.41M 0.6%
1,794,086
+890,135
+98% +$3.24M
MACK
32
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$5.27M 0.5%
1,173,166
-367,469
-24% -$1.84M
RVI
33
DELISTED
Retail Value Inc. Common Shares
RVI
$4.63M 0.44%
1,361,802
-1,723,497
-56% -$5.82M
NIHD
34
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$4.51M 0.42%
2,300,000
+450,100
+24% +$790K
AAOI icon
35
Applied Optoelectronics
AAOI
$7.57B
$3.88M 0.37%
346,050
FWP
36
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$3.27M 0.31%
458,529
+297,500
+185% +$1.98M
GTX icon
37
CALL
Garrett Motion
GTX
$5.81B
$3.21M 0.3%
+322,800
New +$3.97M
FTK icon
38
Flotek Industries
FTK
$852M
$2.59M 0.24%
+196,181
New +$2.99M
TBPH icon
39
Theravance Biopharma
TBPH
$874M
$1.24M 0.12%
+63,681
New +$1.29M
VRTS icon
40
Virtus Investment Partners
VRTS
$1.06B
-75,000
Closed -$8.05M

Similar funds

Newtyn Management's Q3 2019 Portfolio in Review

As of Q3 2019, Newtyn Management held 41 positions worth $1.06B, up 37% from $774M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Newtyn Management deployed $463M of net new capital in Q3 2019, opening 9 new positions and adding to 15 existing holdings. Its largest new stake was Bally's: 758,583 shares worth $17.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 12% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Adient, an estimated $21M trimmed.

  • Newtyn Management's largest Q3 2019 buy was Bally's: 758,583 shares worth $17.3M.
  • Newtyn Management added most to Altaba Inc in Q3 2019, an estimated $65.5M increase.
  • Newtyn Management's biggest Q3 2019 reduction was Adient, cutting an estimated $21M.
  • Newtyn Management fully exited Virtus Investment Partners in Q3 2019, selling an estimated $8.05M.
  • Newtyn Management's ten largest holdings make up 68% of its $1.06B portfolio in Q3 2019.
  • Newtyn Management opened 9 new positions and closed 1 in Q3 2019.
  • Newtyn Management's portfolio value rose 37% quarter-over-quarter to $1.06B.

Based on Newtyn Management's 13F filing for Q3 2019, filed 14 Nov 2019.